title: Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement.
abstract: OBJECTIVE
  Predominant concerns of patients undergoing valve replacement surgery are risks of death, stroke, antithrombotic bleeding, and reoperation related to the replacement prosthesis. The purpose of this study was to compare valve-related reoperation, morbidity (permanent impairment), and mortality between bioprostheses and mechanical prostheses for mitral valve replacement.
  
  
  METHODS
  Between 1982 and 1998, a total of 959 bioprostheses were implanted in 943 patients, and a total of 961 mechanical prostheses were implanted in 839 patients. Total follow-ups were 5730 years for bioprostheses and 5271 years for mechanical prostheses. Eight variables were considered as predictors of risk for the composites of valve-related complications.
  
  
  RESULTS
  The linearized occurrence rates for valve-related reoperation were 3.7 events/100 patient-years for bioprostheses and 0.5 events/100 patient-years for mechanical prostheses ( P < .001), with all age groups differentiated except older than 70 years. Valve-related morbidity was undifferentiated for bioprostheses and mechanical prostheses. Valve-related mortalities were 1.7 events/100 patient-years for bioprostheses and 0.7 events/100 patient-years for mechanical prostheses ( P < .001). Predictors of valve-related reoperation were age and valve type. The only predictor of valve-related morbidity was age, whereas age and valve type were predictors for valve-related mortality. Actual freedom from valve-related reoperation favored mechanical prostheses in all age groups except older than 70 years (91.7% +/- 2.0% for bioprostheses at 15 years and 96.7% +/- 1.5% at 12 years for mechanical prostheses). Actual freedom from valve-related morbidity was not different between bioprostheses and mechanical prostheses. Actual freedom from valve-related mortality favored mechanical prostheses in all groups except older than 70 years.
  
  
  CONCLUSIONS
  Comparative evaluation gives high priority in mitral valve replacement for mechanical prostheses relative to bioprostheses for freedom from valve-related reoperation and valve-related mortality but not valve-related morbidity. Freedom from valve-related reoperation and valve-related mortality favors mechanical prostheses for all age groups except older than 70 years. Valve-related morbidity, due to neurologic or functional impairments, does not differentiate between bioprostheses and mechanical prostheses.
authors.affiliation: University of British Columbia, Vancouver, British Columbia, Canada. wrej@interchange.ubc.ca
authors.forename: W R E
authors.initials: WR
authors.lastname: Jamieson
authors.forename: O
authors.initials: O
authors.lastname: von Lipinski
authors.forename: R T
authors.initials: RT
authors.lastname: Miyagishima
authors.forename: L H
authors.initials: LH
authors.lastname: Burr
authors.forename: M T
authors.initials: MT
authors.lastname: Janusz
authors.forename: H
authors.initials: H
authors.lastname: Ling
authors.forename: G J
authors.initials: GJ
authors.lastname: Fradet
authors.forename: F
authors.initials: F
authors.lastname: Chan
authors.forename: E
authors.initials: E
authors.lastname: Germann
mesh_terms: D000328:Adult; D000368:Aged; D001705:Bioprosthesis / Q000009:adverse effects*; D018572:Disease-Free Survival; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology; D012086:Reoperation / Q000706:statistics & numerical data; D013997:Time Factors